Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	20,049	25,006	11,703	10,129	8,835	10,576
Market Cap Growth	11.34%	113.68%	15.54%	14.65%	-16.46%	-1.18%
Enterprise Value	35,291	41,281	30,334	30,275	31,945	35,841
Last Close Price	17.48	22.04	10.44	9.12	8.01	9.65
PE Ratio	-	-	-	-	21.19	-
Forward PE	6.90	8.35	4.21	3.63	3.02	3.76
PS Ratio	1.19	1.51	0.74	0.68	0.56	0.64
PB Ratio	3.20	4.37	1.44	1.18	0.79	0.96
P/FCF Ratio	26.21	33.39	13.90	9.72	37.44	16.58
P/OCF Ratio	15.84	20.05	8.56	6.37	11.07	8.70
PEG Ratio	0.86	6.69	0.40	1.63	0.68	0.54
EV/Sales Ratio	2.12	2.50	1.91	2.03	2.01	2.15
EV/EBITDA Ratio	7.93	9.32	7.00	7.63	7.25	7.77
EV/EBIT Ratio	10.32	12.24	9.54	11.37	10.38	11.73
EV/FCF Ratio	46.13	55.12	36.03	29.06	135.36	56.18
Debt / Equity Ratio	2.70	3.18	2.50	2.52	2.10	2.40
Debt / EBITDA Ratio	3.69	3.98	4.53	5.26	5.19	5.57
Debt / FCF Ratio	22.14	24.28	24.08	20.80	99.97	41.59
Asset Turnover	0.41	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.35	2.41	2.09	2.08	2.02	2.02
Quick Ratio	0.46	0.50	0.54	0.57	0.61	0.51
Current Ratio	1.03	0.98	1.02	1.05	1.14	0.99
Return on Equity (ROE)	-19.11%	-28.30%	-7.36%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	5.27%	5.09%	4.54%	3.63%	3.91%	3.53%
Return on Capital (ROIC)	8.44%	8.06%	6.78%	5.11%	5.31%	4.77%
Return on Capital Employed (ROCE)	12.60%	12.70%	10.20%	8.20%	8.40%	8.20%
Earnings Yield	-6.41%	-6.55%	-4.78%	-24.15%	4.72%	-37.73%
FCF Yield	3.82%	3.00%	7.20%	10.29%	2.67%	6.03%
Buyback Yield / Dilution	-1.23%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Shareholder Return	-	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q